NOVOZYMES A S DKK 2.0 - COM

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / COM
Price per share
$61.01
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
24,215
Total reported value
$1,477,379
% of total 13F portfolios
0%
Share change
-3,396
Value change
-$240,927
Avg sell value change
-0%
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
As of 30 Sep 2025, NOVOZYMES A S DKK 2.0 - COM has 2 institutional shareholders filing 13F forms. They hold 24,215 shares. .

Institutional Holders of NOVOZYMES A S DKK 2.0 - COM across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q3 24,215 $1,477,379 -$240,927 6,101.1% 2
2025 Q2 27,611 $1,976,013 +$264,508 7,156.62% 3
2025 Q1 23,915 $1,386,701 -$323,607 5,798.45% 2
2024 Q4 29,611 $1,672,027 -$573,260 5,646.64% 3
2024 Q3 37,745 $2,711,896 -$1,154,954 7,184.78% 5
2024 Q2 53,820 $3,283,963 -$547,632 6,101.76% 5
2024 Q1 62,795 $3,671,645 -$327,610 5,847.03% 5
2023 Q4 68,398 $3,748,994 -$659,142 5,481.15% 5
2023 Q3 82,070 $3,303,858 -$429,538 4,025.66% 6
2023 Q2 92,740 $4,307,328 -$708,739 4,644.52% 6
2023 Q1 107,439 $5,470,320 -$957,214 5,091.56% 7
2022 Q4 126,239 $6,374,772 -$1,350,573 5,049.77% 7
2022 Q3 152,989 $7,712,000 -$1,271,694 5,041.33% 8
2022 Q2 170,992 $10,243,000 -$3,895,306 5,990.02% 7
2022 Q1 235,102 $16,154,000 -$6,208,239 6,871.94% 8
2021 Q4 325,450 $26,678,000 -$9,371,894 8,197.95% 8
2021 Q3 439,773 $30,048,000 -$8,065,048 6,832.76% 8
2021 Q2 557,814 $41,951,000 -$13,168,991 7,520.76% 8
2021 Q1 732,914 $46,809,000 -$2,916,809 6,386.25% 8
2020 Q4 778,585 $44,573,000 -$935,611 5,724.75% 8
2020 Q3 794,928 $49,941,000 -$456,947 6,282.45% 8
2020 Q2 885,361 $51,034,000 -$568,563 5,764.39% 12
2020 Q1 895,225 $40,791,000 +$29,518 4,556.71% 12
2019 Q4 894,577 $43,655,000 -$445,717 4,879.79% 12
2019 Q3 903,710 $37,897,000 +$21,843 4,193.57% 12
2019 Q2 903,189 $41,991,000 -$278,644 4,649.07% 12
2019 Q1 909,181 $41,705,000 +$772,574 4,587.26% 12
2018 Q4 892,335 $39,740,000 -$1,132,944 4,453.56% 12
2018 Q3 917,771 $50,227,000 +$15,880 5,472.26% 12
2018 Q2 917,479 $46,478,000 -$415,834 5,065.93% 12
2018 Q1 925,687 $47,715,000 -$1,863,522 5,154.69% 12
2017 Q4 961,837 $54,793,000 -$794,195 5,696.98% 12
2017 Q3 975,792 $49,969,000 +$13,351 5,120.94% 12
2017 Q2 975,530 $42,694,000 +$910,264 4,376.09% 12
2017 Q1 954,751 $37,842,000 +$1,417,959 3,963.37% 11
2016 Q4 918,976 $31,685,000 +$34,129 3,447.6% 11
2016 Q3 917,992 $40,378,000 +$1,143,899 4,398.61% 11
2016 Q2 891,994 $42,903,000 +$845,500 4,809.72% 11
2016 Q1 874,414 $39,308,000 +$749,738 4,495.45% 11
2015 Q4 857,736 $41,297,000 +$2,227,278 4,814.74% 11
2015 Q3 827,241 $36,040,000 +$569,008 4,356.65% 9
2015 Q2 814,181 $38,704,000 +$233,736 4,753.93% 9
2015 Q1 809,265 $37,037,000 +$2,451,249 4,576.83% 9
2014 Q4 802,689 $33,881,000 +$47,213 4,221.06% 10
2014 Q3 801,582 $34,781,000 +$34,620 4,338.81% 10
2014 Q2 800,782 $40,167,000 -$739,159 5,015.8% 10
2014 Q1 815,517 $35,862,000 +$73,691 4,397.31% 10